Personalised Lung Cancer Screening (PLuS) study to assess the importance of coexisting chronic conditions to clinical practice and policy: protocol for a multicentre observational study

INTRODUCTION: Lung cancer is the leading cause of cancer death in the USA and worldwide, and lung cancer screening (LCS) with low-dose CT (LDCT) has the potential to improve lung cancer outcomes. A critical question is whether the ratio of potential benefits to harms found in prior LCS trials applie...

Descripción completa

Detalles Bibliográficos
Autores principales: Braithwaite, Dejana, Karanth, Shama D, Slatore, Christopher G, Zhang, Dongyu, Bian, Jiang, Meza, Rafael, Jeon, Jihyoun, Tammemagi, Martin, Schabath, Mattthew, Wheeler, Meghann, Guo, Yi, Hochhegger, Bruno, Kaye, Frederic J, Silvestri, Gerard A, Gould, Michael K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226937/
https://www.ncbi.nlm.nih.gov/pubmed/35732383
http://dx.doi.org/10.1136/bmjopen-2022-064142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226937/
https://www.ncbi.nlm.nih.gov/pubmed/35732383
http://dx.doi.org/10.1136/bmjopen-2022-064142

Ejemplares similares